Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

China Pharma Holdings (CPHI) Shares Outstanding (Weighted Average) (2016 - 2025)

China Pharma Holdings filings provide 16 years of Shares Outstanding (Weighted Average) readings, the most recent being $4.3 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 145.73% to $4.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.3 million, a 145.73% increase, with the full-year FY2025 number at $4.3 million, up 145.73% from a year prior.
  • Shares Outstanding (Weighted Average) hit $4.3 million in Q4 2025 for China Pharma Holdings, up from $3.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $45.6 million in Q2 2021 to a low of $1.3 million in Q1 2024.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $3.3 million (2025), compared with a mean of $5.6 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): crashed 89.48% in 2022 and later skyrocketed 145.73% in 2025.
  • China Pharma Holdings' Shares Outstanding (Weighted Average) stood at $4.6 million in 2021, then rose by 3.91% to $4.8 million in 2022, then fell by 29.41% to $3.4 million in 2023, then crashed by 48.39% to $1.7 million in 2024, then skyrocketed by 145.73% to $4.3 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $4.3 million (Q4 2025), $3.5 million (Q3 2025), and $3.3 million (Q2 2025) per Business Quant data.